期刊文献+

HPLC法测定盐酸非索非那定缓释微丸胶囊的含量 被引量:1

Determination of Fexofenadine Hydrochloride Sustained Release Pellets Capsules by HPLC
下载PDF
导出
摘要 目的:建立以高效液相色谱法测定盐酸非索非那定缓释微丸胶囊中盐酸非索非那定含量的方法。方法:以Kromasil C_(18_(250 mm×4.6 mm,5μm)为色谱柱,流动相为乙腈-0.5%磷酸二氢钾溶液(以磷酸调节pH至4.0)(55:45),检测波长为210 nm,流速为1.0 ml·min^(-1),柱温为35℃,进样量为20μl。结果:盐酸非索非那定在30.23~302.30μg·ml^(-1)范围内线性关系良好(r=0.999 7),平均回收率为99.75%,RSD=0.1%(n=6)。结论:本方法简便、准确、专属性强,可用于该制剂的含量测定。 Objective: To establish an HPLC method for the determination of fexofenadine hydrochloride sustained release pellets capsules. Method: An HPLC method was performed on a Kromasil Cjs (250 mm x 4.6 mm,5 ) column using acetonitrile -0.5% potassium dihydrogen phosphate solution (55: 45, adjusting pH to 4.0 with phosphate) as the mobile phase at a flow rate of 1.0 ml ~ min-I. The detection wavelength was at 210 nm. The column temperature was 35% and the sample volume was 20 . Result: The linear range of fexofenadine hydrochloride was 30.23-302.30 ~g ~ ml - 1 ( r = 0. 999 7 ), and the average recovery was 99.75% ( RSD = 0.1%, n = 6). Conclusion: The method is simple, accurate and specific, and can be used in the determination of fexofenadine hydro- chloride sustained release pellets capsules.
出处 《中国药师》 CAS 2013年第11期1704-1705,共2页 China Pharmacist
关键词 盐酸非索非那定缓释微丸胶囊 高效液相色谱法 含量测定 Fexofenadine hydrochloride sustained release pellets capsules HPLC Determination
  • 相关文献

参考文献2

二级参考文献5

共引文献2

同被引文献12

  • 1Kittisupamongkol W. Morphine as ananalgesic that causes vomiting [ J ]. Southern Medical Journal ,2009,102 (5) :554.
  • 2Eugene R, David R, Thomas L,et al. Pharmacokineties of extended-re- lease epidural morphine sulfate:peoled analysis of six clinical studies [ J ]. The Veterinary Journal ,2009,181 (3) :299-304.
  • 3Declan W ,Pamela S. Long-term rectal administration of high-dose Sus- tained-release morphine tablets [ J ]. Supportive Care in Cancer,2002, 10(8) :571-659.
  • 4Schwarz P,Schwarz H,East S,et al. Prescription products Moraxen sup- positories [ J]. The Pharmaceutical Journal,2000,265:378.
  • 5Yong CS,Choi JS,Quan QZ,et a/. Effect of sodium chloride on the ge- lation temperature, gel strength and bioadhesive force of poloxamer gels containing declofenac sodium [ J ]. International Journal of Phar- maceut/cs ,2001,226 ( 2 ) : 195 -205.
  • 6Li J, David B, Holly H, et al. In vitro drug release study of methacrylatepolymer blend system : Effect of polymer blend composition, drug load- ing and solubilizing surfactants on drug release [ J ]. Journal of Materi- als Science-Materials in Medicine ,2010,21 (2) :583-588.
  • 7Qi H, Chen W, Huang C,et al. Development of apoloxamer analogs/car- bopol-based in situ gelling and mueoadhesive ophthalmic delivery sys- tem for puerarin [ J ]. International Journal of Pharmaceutics, 2007, 337 (1-2) : 178-187.
  • 8Yun MO, Choi HG, Jung JH, et al. Development of athermo-reversible insulin liquid suppository with bioavailability enhancement [J]. Inter- national Journal of Pharmaceutics, 1999,189 ( 2 ) : 137 - 145.
  • 9Portenoy RK, Maldonado M, Fitzmartin R,et al. Oral controlled-release morphine sulfate. Analgesic efficacy and side effects of a 100-mg tablet in cancer pain patients[ J]. Cancer, 1989,63 (11 Suppl ) :2284-2288.
  • 10Walsh D, Tropiano PS. Long-term rectal administration of high, dose sustained-release morphine tablets[ J ]. Support Care Cancer, 2002,10 (8) : 653-655.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部